Introduction to Angiotensin-Converting Enzyme (ACE)
Angiotensin-Converting Enzyme, commonly referred to as ACE, is one of the most important enzymes in human physiology, especially for maintaining cardiovascular health. ACE is a type of metallopeptidase that catalyzes the conversion of angiotensin I into angiotensin II—a potent vasoconstrictor that plays a central role in blood pressure regulation. With wide-reaching impacts in nephrology, cardiology, and immunology, ACE has gained considerable interest not only in basic research but also in clinical practice. Furthermore, the advent of precision diagnostics and biotechnology has brought ACE to the forefront of pharmaceutical development, making it an essential target for drug discovery.
Related Products
At Amerigo Scientific, we understand the importance of ACE in biomedical research and clinical diagnostics. As a company committed to innovation, we support the scientific community with top-tier ACE assay kits and a robust range of laboratory tools designed for reliable and sensitive biochemical investigations.
ACE Isoforms: ACE1 vs ACE2
The term "angiotensin-converting enzyme" encompasses two main isoforms: ACE1 and ACE2. Despite sharing structural similarities, these two isoforms serve distinctly different biological roles.
ACE1, often referred to simply as ACE, is primarily involved in the classical renin-angiotensin system. It converts angiotensin I into angiotensin II and also breaks down bradykinin, a vasodilator. As a result, ACE1 facilitates vasoconstriction and increases blood pressure.
ACE2, on the other hand, has gained recent fame due to its role as the entry receptor for the SARS-CoV-2 virus. However, its physiological function is equally critical. ACE2 counterbalances ACE1 activity by converting angiotensin II into angiotensin-(1-7), a peptide with vasodilatory and anti-inflammatory properties. This dual system ensures tight regulation of vascular tone and fluid balance.
Understanding the differences and interactions between ACE1 and ACE2 is essential, especially for researchers studying cardiovascular diseases, hypertension, and emerging infectious diseases like COVID-19. Both isoforms are prime targets for drug development and therapeutic interventions.
Mechanism of Action
ACE primarily functions as a dipeptidyl carboxypeptidase. In the renin-angiotensin system (RAS), renin converts angiotensinogen into angiotensin I, a decapeptide with minimal biological activity. ACE then cleaves angiotensin I by removing a dipeptide, yielding angiotensin II, an octapeptide that is a potent vasoconstrictor.
This reaction is highly dependent on the presence of zinc at the enzyme's active site, which plays a crucial role in the catalytic process. Additionally, chloride ions are known to modulate ACE activity, although their precise function remains under investigation. These ions are believed to influence substrate binding and enzyme conformation.
The produced angiotensin II binds to angiotensin type 1 receptors (AT1R), resulting in vasoconstriction, aldosterone secretion, and increased sodium reabsorption, all of which contribute to elevated blood pressure. Therefore, ACE acts as a central regulator in the cascade that governs cardiovascular function.
Physiological Roles of ACE
The most well-known function of ACE is in blood pressure regulation, but its physiological roles extend far beyond that.
Regulation of Blood Pressure
Through its role in converting angiotensin I to angiotensin II and degrading bradykinin, ACE tightly regulates vascular tone. Angiotensin II narrows blood vessels and increases systemic vascular resistance, thereby raising blood pressure. Simultaneously, by breaking down bradykinin, ACE suppresses vasodilation, further enhancing its hypertensive effects.
Degradation of Peptides
ACE is a promiscuous enzyme that acts on several peptide substrates. It degrades bradykinin, neurotensin, and luteinizing hormone-releasing hormone (LHRH), influencing pain perception, hormonal balance, and inflammatory responses.
Renal Development and Fertility
In the kidney, ACE is essential for nephron maturation. Knockout studies in mice have shown that a deficiency in ACE can result in hypoplastic kidneys and impaired renal function. ACE is also expressed in the testis, where it plays a role in male fertility.
Immune System Modulation
Recent studies suggest that ACE may modulate immune cell functions, particularly macrophage activation and cytokine production. This makes ACE a point of interest in autoimmune diseases and inflammatory responses.
Clinical Relevance of ACE and ACE2
ACE in Hypertension and Cardiovascular Disease
ACE is a proven target for managing hypertension, heart failure, and diabetic nephropathy. ACE inhibitors, such as captopril, enalapril, and lisinopril, block the conversion of angiotensin I to angiotensin II, thereby reducing blood pressure and cardiac workload. These drugs are considered first-line treatments and have revolutionized the management of cardiovascular diseases.
ACE2 and COVID-19
ACE2 has become a household term due to its critical role in SARS-CoV-2 entry into human cells. The spike protein of the virus binds with high affinity to ACE2, facilitating viral entry and replication. This interaction is not only central to COVID-19 pathology but also highlights ACE2's broader role in lung injury and inflammation.
Fig. 1 SARS-CoV-2 life cycle: from binding to ACE2 receptor to shedding (Beyerstedt S, Casaro EB, Rangel ÉB, 2021)
ACE2 expression patterns may influence the severity of COVID-19 symptoms and outcomes, particularly in patients with pre-existing cardiovascular conditions.
Diagnostic and Industrial Applications
ACE and ACE2 are widely studied targets in drug development. The search for novel ACE inhibitors and ACE2 modulators continues, especially with the ongoing demand for better cardiovascular therapies and antiviral strategies.The biochemical activity of ACE can be measured through colorimetric and fluorometric assay kits, which are valuable tools in both research and clinical diagnostics.
Genetic and Structural Insights
Gene Location and Polymorphisms
The human ACE gene is located on chromosome 17q23.3, while the ACE2 gene is found on the X chromosome at Xp22.2. Numerous polymorphisms in the ACE gene have been linked to variations in enzyme activity and susceptibility to diseases like hypertension, coronary artery disease, and Alzheimer's.
The insertion/deletion (I/D) polymorphism in intron 16 of the ACE gene is the most studied variant. Individuals with the D/D genotype typically show higher plasma ACE activity, potentially increasing their risk of cardiovascular events.
Structural Domains
ACE consists of two homologous catalytic domains: the N-domain and the C-domain. Both are capable of processing substrates, but they exhibit differences in substrate specificity and inhibitor sensitivity. This domain architecture provides opportunities for selective drug design—for example, inhibitors that target only the C-domain may reduce blood pressure without affecting other physiological pathways.
High-resolution X-ray crystallography and molecular dynamics simulations have been instrumental in revealing the active site configuration and facilitating structure-based drug discovery.
Conclusion
Angiotensin-Converting Enzyme (ACE) is more than just a regulator of blood pressure, it is a linchpin in cardiovascular biology, immune modulation, and therapeutic development. Its relevance spans basic biochemistry to clinical diagnostics and pharmaceutical innovation.
Amerigo Scientific stands ready to support researchers working on ACE-related projects with cutting-edge tools, assay kits, and expert consultation. As science progresses and challenges evolve, our commitment remains firm: to provide the most reliable and advanced resources to the global life sciences community.
Reference
- Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis. 2021; 40(5):905-919.
.
